Posted by Michael Wonder on 05 Feb 2019
Big pharma firms criticise Dutch campaign to slash drug prices
5 February 2019 - Foreign pharmaceuticals companies in the Netherlands say they are ‘concerned’ that the government is undermining the business climate by trying to force down the price of drugs.
The companies, including MSD, Gilead and Johnson & Johnson unit Janssen, are all members of Amcham, the American chamber of commerce in the Netherlands, which has written to health minister Bruno Bruins calling for a rethink.
The organisation says Bruins is not sufficiently aware of the investment needed to develop new drugs and that the return on investment in the sector has now shrunk to 1.9%. This, Amcham says, ‘is too low to ensure the sector remains attractive for investors’.
